Sponsored Links
| ARIAD Announces Initial Clinical Data On Ponatinib In Patients With Relapsed Or Refractory Acute Myeloid Leukemia |
 |
 |
 |
| Medical News - Lymphoma and Leukemia | |
|
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced initial clinical findings on ponatinib in patients with advanced acute myeloid leukemia (AML)... Read more: Lymphoma / Leukemia / Myeloma News From Medical News Today
|